Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03415425 · ClinicalTrials.gov registry record · NA
Optimizing the Influenza Clinical Decision Support Tool
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 25,881
- Enrollment target
NCT03415425: Completed NA study, sponsored by NYU Langone Health.
NCT03415425 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 25,881 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1745% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03415425, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 25,881 participants
- Enrollment target
Study Summary
The proposed study aims to examine several iterations of the Influenza Best Practice Alert at NYU Langone Health. The goal is to increase ordering of the influenza vaccine through the alert.
Primary Outcome
Number of times alert fires in medical record within 2 Month period
Interventions
- OTHER Current Version of the Influenza Alert
- OTHER Alternate Modifications of the Influenza Alert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25,881 participants |
| Start Date | 2018-01-16 |
| Est. Completion | 2023-11-21 |
| Phase | NA |
What the finished NCT03415425 record still lists
NCT03415425 is an interventional study that assigns participants to a tested intervention. Its 25,881 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1745% higher).
The record links to 0 conditions, and to 2 interventions - of which Current Version of the Influenza Alert is the first listed.
NCT03415425 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03415425 about?
NCT03415425 is a clinical study titled "Optimizing the Influenza Clinical Decision Support Tool". The proposed study aims to examine several iterations of the Influenza Best Practice Alert at NYU Langone Health. The goal is to increase ordering of the influenza vaccine through the alert.
What is the current status of trial NCT03415425?
This trial is currently completed. It is a NA study. The enrollment target is 25,881 participants. The study started on 2018-01-16. Estimated completion is 2023-11-21.
What interventions are being tested in trial NCT03415425?
The interventions under investigation include: Current Version of the Influenza Alert (OTHER), Alternate Modifications of the Influenza Alert (OTHER).
Who is sponsoring clinical trial NCT03415425?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03415425's enrollment target sits among peer trials
25,881 9th of 2000 higher than 1,992 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07300839 · 25,500 participants · Phase 3
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
- NCT03175302 · 25,240 participants
PREsurgical Cognitive Evaluation Via Digital clockfacEdrawing
- NCT04595201 · 25,000 participants
Clinical Follow-up of Pregnant Subjects Undergoing NIPT
- NCT04994015 · 25,000 participants
Parkinson's Foundation PD GENEration Genetic Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI